Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4628 | 0.4172 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.5538 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.4628 | 0.4628 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1961 | 0.128 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Leishmania major | DNA polymerase kappa, putative | 0.0021 | 0.1961 | 0.128 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.3752 | 0.3223 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0014 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Echinococcus multilocularis | dna polymerase eta | 0.0014 | 0.0781 | 0.0781 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0.1961 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4628 | 0.4172 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.4628 | 0.4628 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0014 | 0.0781 | 0.0781 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0014 | 0.0781 | 0.0781 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.004 | 0.5538 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.5538 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0014 | 0.0781 | 0.0781 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Trypanosoma brucei | unspecified product | 0.0034 | 0.4358 | 0.3879 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0038 | 0.5027 | 0.5027 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0014 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0034 | 0.4358 | 0.3879 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.7443 | 0.7443 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0065 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0021 | 0.1961 | 0.128 |
Brugia malayi | hypothetical protein | 0.0035 | 0.4628 | 0.4628 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0014 | 0.0781 | 0.0781 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0065 | 1 | 1 |
Brugia malayi | polk-prov protein | 0.0031 | 0.3752 | 0.3752 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0781 | 0.0781 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0.1961 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4628 | 0.4172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.1158 | 0.0408 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.5538 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Toxoplasma gondii | BRCA1 C Terminus (BRCT) domain-containing protein | 0.0011 | 0.0176 | 0.5 |
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0014 | 0.0781 | 0.0781 |
Echinococcus multilocularis | dna polymerase kappa | 0.004 | 0.5538 | 0.5538 |
Schistosoma mansoni | DNA polymerase eta | 0.0014 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.5538 | 0.516 |
Echinococcus granulosus | dna polymerase kappa | 0.004 | 0.5538 | 0.5538 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.4628 | 0.4628 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.3752 | 0.3752 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4628 | 0.4172 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0065 | 1 | 1 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0038 | 0.5027 | 0.5027 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.3752 | 0.3223 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.004 | 0.5538 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.0014 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.1158 | 0.0408 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.4628 | 0.4628 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.5538 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.1158 | 0.0408 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0065 | 1 | 1 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0065 | 1 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0065 | 1 | 1 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0065 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.